Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model

NeuroToxicology

Volumn 53, Issue , 2016, Pages 302-313

  Charli, Adhithiya ^a   Jin, Huajun ^a   Anantharam, Vellareddy ^a   Kanthasamy, Arthi ^a   Kanthasamy, Anumantha G ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Mitochondrial dysfunction; Neurotoxicity; Oxidative stress; Pesticides; Pyridaben; Seahorse; Tebufenpyrad

Indexed keywords

ACARICIDE; ADENOSINE TRIPHOSPHATE; PYRIDABEN; ROTENONE; TEBUFENPYRAD; UNCLASSIFIED DRUG; 4-CHLORO-N-((4-(1,1-DIMETHYLETHYL)PHENYL)METHYL)-3-ETHYL-1-METHYL-1H-PYRAZOLE-5-CARBOXAMIDE; ACONITATE HYDRATASE; NEUROTOXIN; PYRAZOLE DERIVATIVE; PYRIDAZINE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANALYZER; ARTICLE; BIOENERGY; CELL ASSAY; CELL FUNCTION; CELL RESPIRATION; CELL STRUCTURE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONFOCAL FLUORESCENCE IMAGING; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; EC50; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; MEASUREMENT; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR MODEL; MORPHOMETRICS; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SEAHORSE ANALYZER; ANIMAL; APOPTOSIS; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MITOCHONDRIAL DYNAMICS; OXYGEN CONSUMPTION; RAT; TRANSFORMED CELL LINE; ULTRASTRUCTURE;

ACONITATE HYDRATASE; ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; MITOCHONDRIAL DYNAMICS; NEUROTOXINS; OXYGEN CONSUMPTION; PYRAZOLES; PYRIDAZINES; RATS; REACTIVE OXYGEN SPECIES;

EID: 84936818210     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2015.06.007     Document Type: Article

References (56)

1. Adams F.S., La Rosa F.G., Kumar S., Edwards-Prasad J., Kentroti S., Vernadakis A., et al. Characterization and transplantation of two neuronal cell lines with dopaminergic properties. Neurochem. Res. 1996, 21:619-627.
2. Anantharam V., Kitazawa M., Wagner J., Kaul S., Kanthasamy A.G. Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J. Neurosci. 2002, 22:1738-1751.
3. Asaithambi A., Ay M., Jin H., Gosh A., Anantharam V., Kanthasamy A., et al. Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress. PLoS ONE 2014, 9:e96947.
4. Baltazar M.T., Dinis-Oliveira R.J., de Lourdes Bastos M., Tsatsakis A.M., Duarte J.A., Carvalho F. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases - a mechanistic approach. Toxicol. Lett. 2014, 230:85-103.
5. Bazylewicz-Walczak B., Majczakowa W., Szymczak M. Behavioral effects of occupational exposure to organophosphorous pesticides in female greenhouse planting workers. Neurotoxicology 1999, 20:819-826.
6. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3:1301-1306.
7. Cabeza-Arvelaiz Y., Schiestl R.H. Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases. PLoS ONE 2012, 7:e44700.
8. Calvert G.M., Rodriguez L., Prado J.B. Worker illness related to newly marketed pesticides - Douglas County, Washington, 2014. MMWR Morb Mortal Wkly Rep 2015, 64:42-44. CfDCaP (CDC).
9. 2-mediated neurotoxicity in rat primary mesencephalic cultures. PLoS ONE 2009, 4:e7095.
10. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
11. Dagda R.K., Cherra S.J., Kulich S.M., Tandon A., Park D., Chu C.T. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 2009, 284:13843-13855.
12. Degli Esposti M. Inhibitors of NADH-ubiquinone reductase: an overview. Biochim. Biophys. Acta 1998, 1364:222-235.
13. Dranka B.P., Benavides G.A., Diers A.R., Giordano S., Zelickson B.R., Reily C., et al. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic. Biol. Med. 2011, 51:1621-1635.
14. Dranka B.P., Hill B.G., Darley-Usmar V.M. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 2010, 48:905-914.
15. Dranka B.P., Zielonka J., Kanthasamy A.G., Kalyanaraman B. Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation. J. Neurochem. 2012, 122:941-951.
16. Drechsel D.A., Patel M. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic. Biol. Med. 2008, 44:1873-1886.
17. Freire C., Koifman S. Pesticide exposure and Parkinson's disease: epidemiological evidence of association. Neurotoxicology 2012, 33:947-971.
18. Gardner P.R. Aconitase: sensitive target and measure of superoxide. Methods Enzymol. 2002, 349:9-23.
19. Ghosh A., Chandran K., Kalivendi S.V., Joseph J., Antholine W.E., Hillard C.J., et al. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radic. Biol. Med. 2010, 49:1674-1684.
20. Ghosh S., Patel N., Rahn D., McAllister J., Sadeghi S., Horwitz G., et al. The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells. Mol. Pharmacol. 2007, 71:1695-1702.
21. Gollamudi S., Johri A., Calingasan N.Y., Yang L., Elemento O., Beal M.F. Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease. PLoS ONE 2012, 7:e36191.
22. Gordon R., Hogan C.E., Neal M.L., Anantharam V., Kanthasamy A.G., Kanthasamy A. A simple magnetic separation method for high-yield isolation of pure primary microglia. J. Neurosci. Methods 2010, 194:287-296.
23. Grandjean P., Harari R., Barr D.B., Debes F. Pesticide exposure and stunting as independent predictors of neurobehavioral deficits in Ecuadorian school children. Pediatrics 2006, 117:e546-e556.
24. Greenamyre J.T., Cannon J.R., Drolet R., Mastroberardino P.G. Lessons from the rotenone model of Parkinson's disease. Trends Pharmacol. Sci. 2010, 31:141-142. author reply 2-3.
25. Greenamyre J.T., Sherer T.B., Betarbet R., Panov A.V. Complex I and Parkinson's disease. IUBMB Life 2001, 52:135-141.
26. Harischandra D.S., Jin H., Anantharam V., Kanthasamy A., Kanthasamy A.G. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease. Toxicol. Sci. 2014, 143:454-468.
27. Heusinkveld H.J., van den Berg M., Westerink R.H. In vitro dopaminergic neurotoxicity of pesticides: a link with neurodegeneration?. Vet. Q. 2014, 34:120-131.
28. Hoppins S., Lackner L., Nunnari J. The machines that divide and fuse mitochondria. Annu. Rev. Biochem. 2007, 76:751-780.
29. Jekabsons M.B., Nicholls D.G. In situ respiration and bioenergetic status of mitochondria in primary cerebellar granule neuronal cultures exposed continuously to glutamate. J. Biol. Chem. 2004, 279:32989-33000.
30. Jin H., Kanthasamy A., Anantharam V., Rana A., Kanthasamy A.G. Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death. J. Biol. Chem. 2011, 286:19840-19859.
31. Jin H., Kanthasamy A., Ghosh A., Anantharam V., Kalyanaraman B., Kanthasamy A.G. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochim. Biophys. Acta 2014, 1842:1282-1294.
32. Jin H., Kanthasamy A., Ghosh A., Yang Y., Anantharam V., Kanthasamy A.G. α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J. Neurosci. 2011, 31:2035-2051.
33. Jin H., Kanthasamy A., Harischandra D.S., Kondru N., Ghosh A., Panicker N., et al. Histone hyperacetylation upregulates PKCdelta in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson's disease. J. Biol. Chem. 2014, 289:34743-34767.
34. Johnson M.E., Bobrovskaya L. An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology 2015, 46:101-116.
35. Kalyanaraman B. Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms. Redox. Biol. 2013, 1:244-257.
36. Khan A., Gillis K., Clor J., Tyagarajan K. Simplified evaluation of apoptosis using the Muse cell analyzer. Postepy Biochem. 2012, 58:492-496.
37. Latchoumycandane C., Anantharam V., Jin H., Kanthasamy A. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease. Toxicol. Appl. Pharmacol. 2011, 256:314-323.
38. Levesque S., Wilson B., Gregoria V., Thorpe L.B., Dallas S., Polikov V.S., et al. Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 2010, 133:808-821.
39. Lin M., Chandramani-Shivalingappa P., Jin H., Ghosh A., Anantharam V., Ali S., et al. Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells. Neuroscience 2012, 210:308-332.
40. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
41. Marusiak A.A., Edwards Z.C., Hugo W., Trotter E.W., Girotti M.R., Stephenson N.L., et al. Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors. Nat. Commun. 2014, 5:3901.
42. Meijer M., Hendriks H.S., Heusinkveld H.J., Langeveld W.T., Westerink R.H. Comparison of plate reader-based methods with fluorescence microscopy for measurements of intracellular calcium levels for the assessment of in vitro neurotoxicity. Neurotoxicology 2014, 45:31-37.
43. Parron T., Requena M., Hernandez A.F., Alarcon R. Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol. Appl. Pharmacol. 2011, 256:379-385.
44. Prasad K.N., Clarkson E.D., La Rosa F.G., Edwards-Prasad J., Freed C.R. Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: a review. Mol. Genet. Metab. 1998, 65:1-9.
45. Rogers G.W., Brand M.D., Petrosyan S., Ashok D., Elorza A.A., Ferrick D.A., et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS ONE 2011, 6:e21746.
46. Roth B.L., Poot M., Yue S.T., Millard P.J. Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl. Environ. Microbiol. 1997, 63:2421-2431.
47. Sauerbeck A., Pandya J., Singh I., Bittman K., Readnower R., Bing G., et al. Analysis of regional brain mitochondrial bioenergetics and susceptibility to mitochondrial inhibition utilizing a microplate based system. J. Neurosci. Methods 2011, 198:36-43.
48. Schapira A.H. Mitochondrial dysfunction in Parkinson's disease. Cell Death Differ. 2007, 14:1261-1266.
49. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., et al. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 2003, 23:10756-10764.
50. Sherer T.B., Richardson J.R., Testa C.M., Seo B.B., Panov A.V., Yagi T., et al. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J. Neurochem. 2007, 100:1469-1479.
51. Spivey A. Rotenone and paraquat linked to Parkinson's disease: human exposure study supports years of animal studies. Environ. Health Perspect. 2011, 119:A259.
52. Tanner C.M., Kamel F., Ross G.W., Hoppin J.A., Goldman S.M., Korell M., et al. Rotenone, paraquat, and Parkinson's disease. Environ. Health Perspect. 2011, 119:866-872.
53. Testa C.M., Sherer T.B., Greenamyre J.T. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res. Mol. Brain Res. 2005, 134:109-118.
54. Winklhofer K.F., Haass C. Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 2010, 1802:29-44.
55. Zhang D., Kanthasamy A., Yang Y., Anantharam V., Kanthasamy A. Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J. Neurosci. 2007, 27:5349-5362.
56. Zhang Y., Chan D.C. New insights into mitochondrial fusion. FEBS Lett. 2007, 581:2168-2173.